Ardent Health, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | — | $6.32B | $5.97B | $5.41B | $5.13B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | — | — | — | — | — |
| SG&A Expense | — | $140.8M | $132.4M | $114.6M | $75.3M |
| Operating Income | — | $286.4M | $363.1M | $151.6M | $311.5M |
| Operating Margin | — | 4.5% | 6.1% | 2.8% | 6.1% |
| Interest Expense | — | — | — | — | — |
| Pretax Income | — | $286.4M | $363.1M | $151.6M | $311.5M |
| Income Tax Expense | — | $56.2M | $63.4M | $22.6M | $46.1M |
| Net Income | — | $135.8M | $210.3M | $53.9M | $188.9M |
| Net Margin | — | 2.1% | 3.5% | 1.0% | 3.7% |
| EPS (Basic) | — | $0.96 | $1.59 | $0.43 | $1.50 |
| EPS (Diluted) | — | $0.96 | $1.58 | $0.43 | $1.50 |
| Shares Outstanding (Basic) | 142.9M | 140.8M | 132.4M | 126.1M | 126.1M |
| Shares Outstanding (Diluted) | 142.9M | 141.5M | 132.7M | 126.1M | 126.1M |
| Dividends Per Share | — | — | — | — | — |